Fundraising Fox
Neurobell
3 known investors
Find your way into Neurobell
Sign up to see every warm intro you have to Neurobell
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neurobell team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neurobell develops AI-powered medical technology for continuous monitoring of neonatal brain activity in neonatal intensive care units. The company combines clinical expertise with machine learning to advance neonatal brain monitoring capabilities.
Founders & leadership
MO
Mark O'SullivanCo-founder & CEOMark O'Sullivan is CEO and co-founder of NeuroBell, which develops medical device technology for monitoring brain activity in newborns. He completed PhD and postdoctoral research in the field before leading the company's commercialization and securing over €1 million in non-dilutive grants and €3.6 million in private funding.
Investors · 3
Furthr VClisted by Furthr VCDublin · $54K – $270K
How we know: Furthr VC's portfolio page · Not right? Tell us
Elkstone Capital PartnersreportedDublin
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Neurobell do?
- Neurobell develops AI-powered medical technology for continuous monitoring of neonatal brain activity in neonatal intensive care units. The company combines clinical expertise with machine learning to advance neonatal brain monitoring capabilities.
- Who founded Neurobell?
- Neurobell was founded by Mark O'Sullivan.
- Who are Neurobell's investors?
- Neurobell's investors include Atlantic Bridge Ventures, Furthr VC, Elkstone Capital Partners.